Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Zynerba Pharmaceuticals Inc
Zynerba Pharmaceuticals Inc logo

ZYNE - Zynerba Pharmaceuticals Inc Share News

$5.38 -0.2  -3.4%

Last Trade - 24/01/20

Sector
Healthcare
RiskRating
Speculative
Size
Small Cap
Style
Sucker Stock
Market Cap £95.4m
Enterprise Value £36.1m
Revenue £65.8k
Position in Universe 4112th / 6385
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions ZYNE Dividends
All News
All News Reuters News Company Announcements
BRIEF-Zynerba Pharmaceuticals Announces Achievement Of Enrollment Target In Phase 2 Trial Of Zygel In Autism Spectrum Disorder
13th Jan News
Zynerba Pharmaceuticals Announces that Enrollment is Nearing Completion in Pivotal CONNECT-FX Trial in Fragile X Syndrome
13th Jan News
Zynerba Pharmaceuticals Announces Achievement of Enrollment Target in Phase 2 Trial of Zygel™ in Autism Spectrum Disorder
13th Jan News
Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Fragile X Syndrome with Transdermal Cannabidiol
12th Nov '19 News
BRIEF-Zynerba Pharmaceuticals Q3 Loss Per Share $0.08
6th Nov '19 News
Zynerba Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights
6th Nov '19 News
Zynerba Pharmaceuticals to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
25th Oct '19 News
Zynerba Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
26th Sep '19 News
BUZZ-U.S. STOCKS ON THE MOVE-DavidsTea, Alta Mesa Resources, CannTrust, Overstock.com
18th Sep '19 News
BUZZ-U.S. STOCKS ON THE MOVE-FedEx, Zynerba Pharma, Chewy, Adobe
18th Sep '19 News
BUZZ-Zynerba sinks on trial data of lead drug in epilepsy patients
18th Sep '19 News
BRIEF-Zynerba Pharma Announces Positive Top Line Data From Believe 1 Open Label Phase 2 Study Of Zygel In Developmental And Epileptic Encephalopathies
18th Sep '19 News
Zynerba Pharmaceuticals Announces Positive Top Line Data from BELIEVE 1 Open Label Phase 2 Study of Zygel™ in Developmental and Epileptic Encephalopathies (DEE)
18th Sep '19 News
U.S. RESEARCH ROUNDUP-Atara Biotherapeutics, Enphase Energy, Zynerba Pharmaceuticals
16th Sep '19 News
New Caregiver-Reported Data Further Validate the Use of the Aberrant Behavior Checklist Community: FXS Specific (ABC-CFXS) Subscales to Assess Core Behavioral Symptoms of Fragile X Syndrome (FXS)
5th Sep '19 News
Autism Spectrum Disorder, Fragile X Syndrome, and 22q11.2 Deletion Syndrome Share a Constellation of Sociobehavioral Symptoms
5th Sep '19 News
Zynerba Pharmaceuticals to Present at Two Upcoming Conferences
3rd Sep '19 News
BRIEF-Zynerba Pharmaceuticals Inc Says Entered Into A Controlled Equity OfferingSM Sales Agreement
30th Aug '19 News
Zynerba Pharmaceuticals Announces Poster Presentations at the 22nd Society for the Study of Behavioural Phenotypes (SSBP) Symposium
29th Aug '19 News
BRIEF-Zynerba Pharmaceuticals Inc Files For Mixed Shelf Of Upto $300 Million
6th Aug '19 News
© Stockopedia 2020, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.